Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: A comparison of three methods in a large Australasian cohort
- 20 March 2006
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 310 (1-2) , 20-29
- https://doi.org/10.1016/j.jim.2005.11.011
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosisJournal of Neuroimmunology, 2004
- Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativityMultiple Sclerosis Journal, 2004
- Interferon-β-1b slows progression of atrophy in RRMSNeurology, 2004
- Neutralizing antibodies against IFN- in multiple sclerosis: antagonization of IFN- mediated suppression of MMPsBrain, 2004
- Persistent neutralizing antibodies abolish the interferon β bioavailability in MS patientsNeurology, 2003
- Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratoryJournal of Neurology, Neurosurgery & Psychiatry, 2002
- The Neutralization of Interferons by Antibody. II. Neutralizing Antibody Unitage and Its Relationship to Bioassay Sensitivity: The Tenfold Reduction UnitJournal of Interferon & Cytokine Research, 2001
- Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodiesNeurology, 1999
- A Novel Sensitive and Selective Bioassay for Human Type I InterferonsJournal of Interferon & Cytokine Research, 1998
- [74] Quantitation of neutralization of interferon by antibodyPublished by Elsevier ,1986